NCT02282163View on ClinicalTrials.gov

Evaluation of Safety and Efficacy of Lumason in Pediatric Echocardiography

PHASE3TerminatedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

May 31, 2018

Study Completion Date

August 31, 2018

Conditions
Heart Disease
Interventions
DRUG

sulphur hexafluoride lipid-type A microspheres

Ultrasound imaging contrast agent

Trial Locations (2)

63110

Washington University School of Medicine in Saint Louis, St Louis

68114

University of Nebraska, Omaha

Sponsors
All Listed Sponsors
lead

Bracco Diagnostics, Inc

INDUSTRY